AMGN

SELL

Amgen Inc.

Healthcare · Rank #127 · Analyzed Jul 13, 2026

$363.39

Current Price

$319.63

Intrinsic Value

-12.0%

Upside/Downside

3.5/10

Score

3.5/5

Quality

Analysis Summary

Valuation Consensus0/2 methods agree

Quality Score3.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 12.0%

Fair Value Range

Low$180.94

Base (IV)$319.63

High$355.85

Entry Points

Conservative$126.66

Moderate$180.94

Aggressive$223.74

Quality & Moat Breakdown

Return on Equity101.3% → 1.0/1.0

Debt LevelD/E 624 → 0/1.0

Revenue QualityGrowth -6.4%, margin Δ+45.4% +recovery → 0.5/1.0

Moat Strength4.0/5 → 1.0/1.0

Profit Margins21.0% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.